These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32526325)

  • 1. Reply to Problematic methodology in a systematic review and meta-analysis of DecisionDx-Melanoma.
    Greenhaw BN; Covington KR; Kurley SJ; Yeniay Y; Cao NA; Plasseraud KM; Cook RW; Hsueh EC; Gastman BR; Wei ML
    J Am Acad Dermatol; 2020 Nov; 83(5):e359-e360. PubMed ID: 32526325
    [No Abstract]   [Full Text] [Related]  

  • 2. Problematic methodology in a systematic review and meta-analysis of DecisionDx-Melanoma.
    Marchetti MA; Dusza SW; Bartlett EK
    J Am Acad Dermatol; 2020 Nov; 83(5):e357-e358. PubMed ID: 32526321
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessing Genetic Expression Profiles in Melanoma Prognosis.
    Farberg AS; Glazer AM; Winkelmann RR; Rigel DS
    Dermatol Clin; 2017 Oct; 35(4):545-550. PubMed ID: 28886811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling in melanoma: past results and future potential.
    Knackstedt RW; Knackstedt T; Gastman B
    Future Oncol; 2019 Mar; 15(7):791-800. PubMed ID: 30453756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients.
    Cook RW; Middlebrook B; Wilkinson J; Covington KR; Oelschlager K; Monzon FA; Stone JF
    Diagn Pathol; 2018 Feb; 13(1):13. PubMed ID: 29433548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a prognostic gene expression profile test for T1 cutaneous melanoma: Will it help or harm patients?
    Marchetti MA; Bartlett EK; Dusza SW; Bichakjian CK
    J Am Acad Dermatol; 2019 Jun; 80(6):e161-e162. PubMed ID: 30586612
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to: "Use of a prognostic gene expression profile test for T1 cutaneous melanoma: Will it help or harm patients?".
    Gastman BR; Cook RW
    J Am Acad Dermatol; 2019 Jun; 80(6):e163-e164. PubMed ID: 30586615
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessing Genetic Expression Profiles in Melanoma Diagnosis.
    Leachman SA; Mengden Koon S; Korcheva VB; White KP
    Dermatol Clin; 2017 Oct; 35(4):537-544. PubMed ID: 28886810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
    Zager JS; Gastman BR; Leachman S; Gonzalez RC; Fleming MD; Ferris LK; Ho J; Miller AR; Cook RW; Covington KR; Meldi-Plasseraud K; Middlebrook B; Kaminester LH; Greisinger A; Estrada SI; Pariser DM; Cranmer LD; Messina JL; Vetto JT; Wayne JD; Delman KA; Lawson DH; Gerami P
    BMC Cancer; 2018 Feb; 18(1):130. PubMed ID: 29402264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test.
    Hsueh EC; DeBloom JR; Lee J; Sussman JJ; Covington KR; Middlebrook B; Johnson C; Cook RW; Slingluff CL; McMasters KM
    J Hematol Oncol; 2017 Aug; 10(1):152. PubMed ID: 28851416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients.
    Greenhaw BN; Covington KR; Kurley SJ; Yeniay Y; Cao NA; Plasseraud KM; Cook RW; Hsueh EC; Gastman BR; Wei ML
    J Am Acad Dermatol; 2020 Sep; 83(3):745-753. PubMed ID: 32229276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics Analysis Identifies MicroRNAs and Target Genes Associated with Prognosis in Patients with Melanoma.
    Li Q; Zhang LY; Wu S; Huang C; Liu J; Wang P; Cao Y
    Med Sci Monit; 2019 Oct; 25():7784-7794. PubMed ID: 31621692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reply: Increased mortality for pregnancy-associated melanoma: systematic review and meta-analysis.
    Byrom L; Olsen CM; Green AC
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1618-9. PubMed ID: 25975667
    [No Abstract]   [Full Text] [Related]  

  • 14. Melanoma molecular classes and prognosis in the postgenomic era.
    Tremante E; Ginebri A; Lo Monaco E; Frascione P; Di Filippo F; Terrenato I; Benevolo M; Mottolese M; Pescarmona E; Visca P; Natali PG; Giacomini P
    Lancet Oncol; 2012 May; 13(5):e205-11. PubMed ID: 22554548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable Results for Uveal Melanoma-Specific Gene Expression Profile Prognostic Test in Choroidal Metastasis.
    Klufas MA; Itty S; McCannel CA; Glasgow BJ; Moreno C; McCannel TA
    JAMA Ophthalmol; 2015 Sep; 133(9):1073-6. PubMed ID: 26086628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma.
    Chen W; Cheng P; Jiang J; Ren Y; Wu D; Xue D
    Aging (Albany NY); 2020 Jul; 12(13):12703-12725. PubMed ID: 32639949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Expression Profiling in Cutaneous Melanoma: Caveats for Clinicians.
    Sominidi-Damodaran S; Pittelkow MR; Meves A
    Mayo Clin Proc; 2016 Aug; 91(8):1147-8. PubMed ID: 27492918
    [No Abstract]   [Full Text] [Related]  

  • 18. MicroRNA-sequencing data analyzing melanoma development and progression.
    Linck L; Liebig J; Völler D; Eichner N; Lehmann G; Meister G; Bosserhoff A
    Exp Mol Pathol; 2018 Dec; 105(3):371-379. PubMed ID: 30414979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reply to sentinel lymph node biopsy (SLNB) plus wide local excision vs. wide local excision alone for primary cutaneous melanoma: a systematic review and meta-analysis - SLNB is not associated with a significantly better outcome in melanoma survival.
    Eisendle K
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):e471-e472. PubMed ID: 28380261
    [No Abstract]   [Full Text] [Related]  

  • 20. Early outcome of a 31-gene expression profile test in 86 AJCC stage IB-II melanoma patients. A prospective multicentre cohort study.
    Podlipnik S; Carrera C; Boada A; Richarz NA; López-Estebaranz JL; Pinedo-Moraleda F; Elosua-González M; Martín-González MM; Carrillo-Gijón R; Redondo P; Moreno E; Malvehy J; Puig S
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):857-862. PubMed ID: 30702163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.